<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>Incidence of various Hodgkin (<z:e sem="disease" ids="C0019829" disease_type="Neoplastic Process" abbrv="hd">HL</z:e>) and non-Hodgkin <z:hpo ids='HP_0002665'>lymphoma</z:hpo> (NHL) subtypes and association with viruses in Lebanon are not known </plain></SENT>
<SENT sid="1" pm="."><plain>We undertook a nationwide study of 272 patients diagnosed with <z:hpo ids='HP_0002665'>lymphoma</z:hpo> in 2007 </plain></SENT>
<SENT sid="2" pm="."><plain><z:e sem="disease" ids="C0019829" disease_type="Neoplastic Process" abbrv="hd">HL</z:e> comprised 32.7 % (n = 89) of cases while NHL represented 67.3 % (n = 183) </plain></SENT>
<SENT sid="3" pm="."><plain>Consistent with the literature, nodular <z:mp ids='MP_0000612'>sclerosis</z:mp> was the most predominant <z:e sem="disease" ids="C0019829" disease_type="Neoplastic Process" abbrv="hd">HL</z:e> subtype (n = 57/89) </plain></SENT>
<SENT sid="4" pm="."><plain>Among NHL, B-cell NHL represented 88 % (n = 161/183), T-cell NHL 9 % (n = 17/183), whereas in 2.7 % it was not classifiable </plain></SENT>
<SENT sid="5" pm="."><plain>The B-cell NHL comprised predominantly diffuse large B-cell <z:hpo ids='HP_0002665'>lymphoma</z:hpo> (46 %) and follicular <z:hpo ids='HP_0002665'>lymphoma</z:hpo> (23 %) </plain></SENT>
<SENT sid="6" pm="."><plain>81 cases were reviewed by a panel of pathologists with 87.6 % concordance rate </plain></SENT>
<SENT sid="7" pm="."><plain>Serology was negative for <z:hpo ids='HP_0012115'>hepatitis</z:hpo> C in 122 tested cases </plain></SENT>
<SENT sid="8" pm="."><plain>HIV was positive in 2 cases </plain></SENT>
<SENT sid="9" pm="."><plain>Two adult T-cell <z:hpo ids='HP_0001909'>leukemia</z:hpo>/<z:hpo ids='HP_0002665'>lymphoma</z:hpo> were HTLV-I positive </plain></SENT>
<SENT sid="10" pm="."><plain>EBV IgG were positive in 88.5 % of cases </plain></SENT>
<SENT sid="11" pm="."><plain>38 EBV seropositive cases [27 NHL (24 B-cell, 3 T-cell) and 11 HL] were studied for EBV genome expression using EBV-encoded <z:chebi fb="40" ids="33697">RNA</z:chebi> (EBER)-in situ hybridization </plain></SENT>
<SENT sid="12" pm="."><plain>EBER expression was positive in 8 (21 %) cases (6 HL, 2 T-cell NHL) </plain></SENT>
<SENT sid="13" pm="."><plain>The distribution of <z:hpo ids='HP_0002665'>lymphoma</z:hpo> subtypes in Lebanon appears similar to that of Western countries </plain></SENT>
<SENT sid="14" pm="."><plain>The high rate of EBV positivity in <z:e sem="disease" ids="C0019829" disease_type="Neoplastic Process" abbrv="hd">HL</z:e> and T-cell <z:hpo ids='HP_0002665'>lymphoma</z:hpo> by EBER deserves further investigation </plain></SENT>
</text></document>